138 related articles for article (PubMed ID: 38010064)
1. Single-cell RNA sequencing reveals immune microenvironment of small cell lung cancer-associated malignant pleural effusion.
Wang S; An J; Hu X; Zeng T; Li P; Qin J; Shen Y; Chen M; Wen F
Thorac Cancer; 2024 Jan; 15(1):98-103. PubMed ID: 38010064
[TBL] [Abstract][Full Text] [Related]
2. CD39 identifies a specific CD8 + T cell population in lung adenocarcinoma-related metastatic pleural effusion.
Lv LL; Wang HB; Zhang YX; Zhai JW; Shen Y; Qu QX; Chen C
BMC Immunol; 2023 Dec; 24(1):53. PubMed ID: 38087217
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion.
Shao MM; Pei XB; Chen QY; Wang F; Wang Z; Zhai K
Front Immunol; 2023; 14():1161375. PubMed ID: 37143656
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients.
Zhang Z; Ji W; Huang J; Zhang Y; Zhou Y; Zhang J; Dong Y; Yuan T; Yang Q; Ding X; Tang L; Li H; Yin J; Wang Y; Ji T; Fei J; Zhang B; Chen P; Hu H
Clin Transl Med; 2022 Nov; 12(11):e1072. PubMed ID: 36305631
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-derived CCL22 promotes an immunosuppressive tumor microenvironment via IL-8 in malignant pleural effusion.
Wang D; Yang L; Yue D; Cao L; Li L; Wang D; Ping Y; Shen Z; Zheng Y; Wang L; Zhang Y
Cancer Lett; 2019 Jun; 452():244-253. PubMed ID: 30928379
[TBL] [Abstract][Full Text] [Related]
6. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion.
Huang ZY; Shao MM; Zhang JC; Yi FS; Du J; Zhou Q; Wu FY; Li S; Li W; Huang XZ; Zhai K; Shi HZ
Nat Commun; 2021 Nov; 12(1):6690. PubMed ID: 34795282
[TBL] [Abstract][Full Text] [Related]
7. A novel nano-immunotherapeutic remodels the immune landscape of malignant pleural effusion: Insights into its mechanism of action through single-cell RNA-sequencing.
Liu Y; Zhao D
Clin Transl Med; 2022 Mar; 12(3):e774. PubMed ID: 35297203
[TBL] [Abstract][Full Text] [Related]
8. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
Shojaee S; Singh I; Solsky I; Nana-Sinkam P
Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer.
Wu YY; Hsu YL; Huang YC; Su YC; Wu KL; Chang CY; Ong CT; Lai JC; Shen TY; Lee TH; Hung JY; Tsai YM
Theranostics; 2023; 13(13):4412-4429. PubMed ID: 37649596
[No Abstract] [Full Text] [Related]
10. Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.
Wen Y; Wang Y; Xing Z; Liu Z; Hou Z
Cell Cycle; 2018; 17(24):2819-2832. PubMed ID: 30563416
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion.
Tseng YH; Ho HL; Lai CR; Luo YH; Tseng YC; Whang-Peng J; Lin YH; Chou TY; Chen YM
J Thorac Oncol; 2018 Mar; 13(3):447-453. PubMed ID: 29246835
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of Prognostic Factors and Clinical Characteristics for Patients with Limited Stage Small Cell Lung Cancer with Pleural Effusion].
Xu K; Wang Y; Qi J; Zhao L; Wang P
Zhongguo Fei Ai Za Zhi; 2018 Jan; 21(1):16-23. PubMed ID: 29357968
[TBL] [Abstract][Full Text] [Related]
13. Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients.
Bruschini S; Pallocca M; Sperandio E; D'Ambrosio L; Ascenzi F; De Vitis C; Salvati V; Esposito A; Di Martino S; De Nicola F; Paolini F; Fattore L; Alessandrini G; Facciolo F; Foddai ML; Bassi M; Venuta F; D'Ascanio M; Ricci A; D' Andrilli A; Napoli C; Aurisicchio L; Fanciulli M; Rendina EA; Ciliberto G; Mancini R
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35584864
[TBL] [Abstract][Full Text] [Related]
14. Variations in pleural microbiota and metabolic phenotype associated with malignant pleural effusion in human lung adenocarcinoma.
Huang D; Zhuo J; Ye C; Su X; Chen Y; Li C; Lin L; Liu L; Zhao H; Luo T; Ren Q; Wu J; Cai S; Dong H
Thorac Cancer; 2023 Jul; 14(21):2045-2056. PubMed ID: 37309281
[TBL] [Abstract][Full Text] [Related]
15. Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.
Yang G; Li H; Yao Y; Xu F; Bao Z; Zhou J
Oncol Rep; 2015 Jan; 33(1):478-84. PubMed ID: 25371165
[TBL] [Abstract][Full Text] [Related]
16. Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung Adenocarcinoma.
Song Z; Luo W; Zheng H; Zeng Y; Wang J; Chen T
Adv Healthc Mater; 2021 Jun; 10(12):e2100149. PubMed ID: 33870649
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and functional characterizations of CD8
Zhang Y; Li W; Zhai J; Jin Y; Zhang L; Chen C
Exp Cell Res; 2022 Aug; 417(1):113212. PubMed ID: 35588796
[TBL] [Abstract][Full Text] [Related]
19. Recruitment of IL-1β-producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Li X; Feng J
Thorac Cancer; 2022 Mar; 13(6):811-823. PubMed ID: 35137541
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of soluble H7-B4 in pleural effusion associated with lung cancer.
Xu CH; Cao L; Zhang XW; Yan J; Yu LK
Tumour Biol; 2015 Jun; 36(6):4397-403. PubMed ID: 25636447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
